Valle William, a director at TriSalus Life Sciences, Inc. ($TLSI), made one open market purchase of common shares in the past year, totaling about $125,000. His most recent buy occurred on February 23, 2026. With no open market sales recorded, his purchase amount ranks 1,961st out of 4,983 insiders in our database, below the average of $1.5 million across 3.29 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Valle William | Director | P | Common Stock | 30487 | $4.10 | 30,487.0000 | 49,964,311 | 9999.99% | 0.06% |
| June 12, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Valle William | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 56,250.0000 | 32,272,462 | 36.36% | 0.05% |
| Jan. 29, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Valle William | Not found | A | Director Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Valle William | Not found | A | Director Stock Option (right to buy) | 6250 | $0.00 | 6,250.0000 | 0 | 9999.99% | 0.00% |
| July 16, 2024 | American Oncology Network, Inc. | $AONC | Valle William | Director | A | Class A Common Stock | 5000 | $0.00 | 19,981.0000 | 20,571,323,000 | 33.38% | 0.00% |
| May 4, 2024 | American Oncology Network, Inc. | $AONC | Valle William | Director | A | Class A Common Stock | 14981 | $0.00 | 14,981.0000 | 25,109,551,000 | 9999.99% | 0.00% |